Quest Diagnostics Incorporated (DGX) Earnings History
Annual and quarterly earnings data from 1996 to 2025
Loading earnings history...
DGX EPS Growth (CAGR)
Compound annual growth rate of diluted earnings per share
CAGR (Compound Annual Growth Rate) shows the annualized growth rate of EPS over the specified period. A higher CAGR indicates stronger earnings momentum.
DGX Profitability Analysis
Margin trends over time
| Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| 2025 | 31.9% | 14.5% | 9.0% |
| 2024 | 32.9% | 13.6% | 8.8% |
| 2023 | 33.2% | 13.6% | 9.2% |
| 2022 | 34.7% | 14.4% | 9.6% |
| 2021 | 39.0% | 22.1% | 18.5% |
Download Data
Export DGX earnings history in CSV or JSON format
Free sign-in required to download data
Quest Diagnostics Incorporated (DGX) Earnings Overview
As of May 8, 2026, Quest Diagnostics Incorporated (DGX) reported trailing twelve-month net income of $1.02B, reflecting +13.8% year-over-year growth. The company earned $9.14 per diluted share over the past four quarters, with a net profit margin of 9.0%.
Looking at the long-term picture, DGX's 5-year EPS compound annual growth rate (CAGR) stands at -3.6%, signaling declining earnings. The company achieved its highest annual net income of $2.00B in fiscal 2021.
Quest Diagnostics Incorporated maintains positive profitability with a gross margin of 31.9%, operating margin of 14.5%, and net margin of 9.0%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including LH ($942M net income, 6.3% margin), SLNO ($21M net income, 11.0% margin), EXAS (-$208M net income, -6.4% margin), DGX has outperformed on profitability metrics. Compare DGX vs LH →
DGX Earnings vs Peers
Earnings metrics vs comparable public companies
DGX Historical Earnings Data (1996–2025)
30 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $992M | +13.9% | $1.60B | $8.75 | 9.0% | 14.5% |
| 2024 | $871M | +2.0% | $1.35B | $7.69 | 8.8% | 13.6% |
| 2023 | $854M | -9.7% | $1.26B | $7.52 | 9.2% | 13.6% |
| 2022 | $946M | -52.6% | $1.43B | $7.98 | 9.6% | 14.4% |
| 2021 | $2.00B | +39.4% | $2.38B | $15.53 | 18.5% | 22.1% |
| 2020 | $1.43B | +66.8% | $1.97B | $10.52 | 15.2% | 20.9% |
| 2019 | $858M | +16.6% | $1.23B | $6.29 | 11.1% | 15.9% |
| 2018 | $736M | -4.7% | $1.10B | $5.29 | 9.8% | 14.6% |
| 2017 | $772M | +19.7% | $1.17B | $5.50 | 10.0% | 15.1% |
| 2016 | $645M | -9.0% | $1.28B | $4.51 | 8.6% | 17.0% |
Full DGX Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See DGX's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DGX Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DGX vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonDGX — Frequently Asked Questions
Quick answers to the most common questions about buying DGX stock.
Is DGX growing earnings?
DGX EPS stands at $9.14, with +13.8% growth matching the 5-year CAGR of -3.6%. TTM net income is $1.0B. Earnings trajectory remains consistent.
What are DGX's profit margins?
Quest Diagnostics Incorporated net margin is +9.0%, with operating margin at +14.5%. Margins sit within typical range for the sector.
How consistent are DGX's earnings?
DGX earnings data spans 1996-2025. The current earnings trend is +13.8% YoY. Historical data enables comparison across business cycles.